Vaishnavi Ganti

Vaishnavi Ganti is an accomplished clinical pharmacologist with extensive experience in the pharmaceutical industry. Currently serving as the Director of Clinical Pharmacology Sciences at Gilead Sciences since November 2020, previous roles include Senior Clinical Pharmacologist II/Associate Director at Harpoon Therapeutics and Associate Principal Scientist at Merck. At Harpoon Therapeutics, Ganti represented clinical pharmacology for TriTAC™ programs, overseeing study activities and performing PK and PK/PD analyses. At Merck, responsibilities included conducting PKPD studies and managing pharmacology sub teams. Ganti began a career in research as a Graduate Student at Temple University, contributing to the understanding of chemotherapy-related neurotoxicity and later interned at Pfizer, where pharmacodynamic and PopPK models were developed. Ganti holds a PhD in Pharmaceutical Sciences from Temple University and a Bachelor's degree from Manipal Academy of Higher Education.